Blastomycosis of the central nervous system: A multicenter review of diagnosis and treatment in the modern era

Clinical Infectious Diseases

Volumn 50, Issue 6, 2010, Pages 797-804

  Bariola, J Ryan ^a   Perry, Paul ^b   Pappas, Peter G ^b   Praia, Laurie ^c   Shealey, Wesley ^d   Wright, Patty W ^d   Sizemore, James M ^e   Robinson, Matthew ^f   Bradsher Jr , Robert W ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b University of Alabama at Birmingham   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; FLUCYTOSINE; FUNGUS ANTIGEN; ITRACONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIDURAL ABSCESS; FATALITY; FEMALE; FOLLOW UP; FUNGAL MENINGITIS; FUNGUS CULTURE; HUMAN; IMMUNOCOMPROMISED PATIENT; INTRACRANIAL TUMOR; LUMBAR PUNCTURE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; BLASTOMYCES; BLASTOMYCOSIS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; FEMALE; HEAD; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77749277168     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/650579     Document Type: Article

References (34)

1. Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin North Am 2003;17: 21-40.
2. Chapman SW. Blastomyces dermatitidis. In: Mandell GN, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Vol 2. Philadelphia: Elsevier, 2005: 3026-3040.
3. Klein BS, Vergeront JM, Weeks RJ, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986; 314: 529-534.
4. Armstong CW, Jenkins SR, Kaufman L, Kerkering TM, Rouse BS, Miller GB Jr. Common source outbreak of blastomycosis in hunters and their dogs. J Infect Dis 1987; 155: 568-570. (Pubitemid 17032818)
5. Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 1997; 12: 219-228. (Pubitemid 27411205)
6. Bradsher RW, Rice DC, Abemathy RS. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985; 103: 872-879.
7. Baumgardner DJ, Buggy BP, Mattson BJ, Burdick JS, Ludwig D. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis 1992; 15: 629-635.
8. Lucianao BL, Guo M, Baliga M. Blastomycosis: organ involvement and etiologic diagnosis. A review of 123 patients from Mississippi. Ann Diagn Pathol 2000; 4: 391-406.
9. Gonyea EE The spectrum of primary blastomycotic meningitis: a review of central nervous system blastomycosis. Ann Neurol 1978; 3: 26-39.
10. Fetter BF, Klintworth GK, Hendry WS. Mycoses of the central nervous system. Baltimore: Williams and Wilkins, 1967.
11. Lemos LB, Baliga M, Guo M. Blastomycosis: the great pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol 2002; 6: 194-203.
12. Dworkin MS, Duckro AN, Proia L, Semel JD, Huhn G. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005; 41: e107-e111.
13. Vasquez J, Mehta JB, Agarwal R, Sarubbi F. Blastomycosis in northeast Tennessee. Chest 1998; 114: 436-443.
14. Friedman JA, Wijdicks EF, Fulgham JR, Wright AJ. Meningoencephalitis due to Blastomyces dermatitidis: case report and literature review. Mayo Clin Proc 2000; 75: 403-408.
15. Kravitz GR, Davies SF, Eckman MR, Sarosi GA. Chronic blastomycotic meningitis. Am J Med 1981; 71: 501-505.
16. Morgan D, Young RF, Chow AW Mehringer CM, Itabashi H. Recurrent intracerebral blastomycotic granuloma: diagnosis and treatment. Neurosurgery 1979; 4: 319-324. (Pubitemid 9157492)
17. Roos KL, Bryan JP, Maggio WW, Jane JA, Scheid WM. Intracranial blastomycoma. Medicine (Baltimore) 1987; 66: 224-235.
18. Ward BA, Parent AD, Raila F. Indications for the surgical management of central nervous system blastomycosis. Surg Neurol 1995; 43: 379-388.
19. Craig WM, Carmichael FA Jr. Blastomycoma of the cerebellum: report of a case. Mayo Clin Proc 1938; 13: 347-351.
20. Wylen EL, Nanda A. Blastomyces dermatitidis occurring as an isolated cerebellar mass. Neurosurg Rev 1999; 22: 152-154.
21. Pappas PG, Dismukes WE. Blastomycosis: Gilchrist's disease revisited. Curr Clin Top Infect Dis 2002; 22: 61-77.
22. Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 1801-1812.
23. Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 2000; 182: 274-282.
24. Bakleh M, Aksamit AJ, Tleyjeh IM, Marshall WF. Successful treatment of cerebral blastomycosis with voriconazole. Clin Infect Dis 2005; 40: e69-e71.
25. Panicker J, Walsh T, Kamani N. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole. Pediatr Infect Dis J 2006; 25: 377-379.
26. Borgia SM, Fuller JD, Sarabia A, El-Helou P. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med Mycol 2006; 44: 659-664. (Pubitemid 44650518)
27. Pearson GJ, Chin TW, Fong IW. Case report: treatment of blastomycosis with fluconazole. Am J Med Sci 1992; 303: 313-315.
28. Pappas PG, Bradsher RW, Kaufiman CA, et al. Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycosis Study Group. Clin Infect Dis 1997; 25: 200-205.
29. Lyman CA, Walsh TJ. Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs 1992; 44: 9-35.
30. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330: 263-272. (Pubitemid 24034139)
31. Harley WB, Lomis M, Haas DW. Marked polymorphonuclear pleocytosis due to blastomycotic meningitis: case report and review. Clin Infect Dis 1994; 18: 816-818. (Pubitemid 24145924)
32. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 807-825.
33. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-360. (Pubitemid 351265310)
34. Srinivasan J, Ooi WW. Successful treatment of histoplasmosis brain abscess with voriconazole. Arch Neurol 2008; 65: 666-667. (Pubitemid 351679665)